Hospira was granted a temporary restraining order against the FDA over the agency's approval of generic versions of the company's top-selling drug.
from WSJ.com: US Business http://ift.tt/1tlyyKZ
via IFTTT
from WSJ.com: US Business http://ift.tt/1tlyyKZ
via IFTTT
No comments:
Post a Comment